News | January 12, 2026
AbbVie to acquire West Pharmaceutical’s Arizona device manufacturing facility
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
This drug candidate, which is currently progressing through pivotal clinical studies, has the potential to become the first add-on therapy for schizophrenia patients who do not respond adequately
The company is pursuing the accelerated FDA 505(b)(2) approval pathway for its once-daily oral ondansetron formulation
The decision secures legal protection in China for semaglutide, the blockbuster drug underpinning Novo Nordisk’s diabetes and obesity treatments
The company announced that it has been granted patent covering “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives.”
The Co-Dx PCR platform is designed to deliver gold-standard PCR accuracy in a compact, user-friendly device suitable for decentralized testing environments
Masitinib targets mast cells, which play a critical role in severe forms of SCD and its complications, including vaso-occlusive crises, acute chest syndrome, and pain
The portfolio includes foundational patents on the production, composition, and commercial use of NR
The approval comes with 180 days of Competitive Generic Therapy (CGT) exclusivity,
This recognition demonstrate excellence in intellectual property (IP) value creation.
Subscribe To Our Newsletter & Stay Updated
